ArticleFrontiers in immunology2023

Immune reconstitution following alemtuzumab therapy is characterized by exhausted T cells, increased regulatory control of proinflammatory T cells and reduced B cell control.

Marina Rode von Essen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.